Lags in education and coordination along the reporting chain, among other issues, contributed to the nearly 17-month delay in implementing accurate coding measures, Duke University experts reported.

An MIT spinoff based in Boston and Milan in Italy has earned CE certification for software that flags respiratory infection in wearers of the company’s smartwatch devices.

The Israel-based startup is spending about $40 million on the facility, which it hopes to have up and running in the first quarter of 2022, officials said Wednesday. 

More consolidation across the healthcare sector is on the horizon thanks in part to the COVID-19 pandemic, according to an opinion by Commonwealth Fund leaders published in Harvard Business Review.

Also, FDA clears Siemens' new PET/CT scanner, Varian CEO stepping down, and vRad scores its 23rd patent. 

A manufacturer of compact MRI machines that leverage AI to upgrade image quality has received FDA’s blessing to market its technology in the U.S.

The Los Angeles-based operator has revised its investor guidance for 2021 to account for the rosier picture amid lifting COVID restrictions. 

The COVID crisis has spurred clinical researchers to look myriad ways AI might help win the war against the virus. Has the investigatory boomlet ended up raising as many nettlesome concerns as positive possibilities?